These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 21830268

  • 1. Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea.
    Ye BD, Yang SK, Boo SJ, Cho YK, Yang DH, Yoon SM, Kim KJ, Byeon JS, Myung SJ, Yu CS, Yun SC, Kim JH.
    Inflamm Bowel Dis; 2011 Sep; 17(9):1901-6. PubMed ID: 21830268
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
    Lindberg J, Stenling R, Palmqvist R, Rutegård J.
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
    [Abstract] [Full Text] [Related]

  • 5. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.
    Loftus EV, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, Jewell DA, Sandborn WJ.
    Gut; 2005 Jan; 54(1):91-6. PubMed ID: 15591511
    [Abstract] [Full Text] [Related]

  • 6. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
    Boonstra K, van Erpecum KJ, van Nieuwkerk KM, Drenth JP, Poen AC, Witteman BJ, Tuynman HA, Beuers U, Ponsioen CY.
    Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
    [Abstract] [Full Text] [Related]

  • 7. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L, Mester G, Erdélyi Z, David G, Pandúr T, Balogh M, Fischer S, Vargha P, Lakatos PL.
    Orv Hetil; 2006 Jan 29; 147(4):175-81. PubMed ID: 16515026
    [Abstract] [Full Text] [Related]

  • 8. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M, Fournier N, Safroneeva E, Pittet V, Godat S, Straumann A, Nydegger A, Vavricka SR, Moradpour D, Schoepfer AM, Swiss IBD Cohort Study Group.
    Eur J Gastroenterol Hepatol; 2017 Jan 29; 29(1):91-97. PubMed ID: 27622999
    [Abstract] [Full Text] [Related]

  • 9. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
    Navaneethan U, Kochhar G, Venkatesh PG, Lewis B, Lashner BA, Remzi FH, Shen B, Kiran RP.
    Gastrointest Endosc; 2012 May 29; 75(5):1045-1054.e1. PubMed ID: 22405258
    [Abstract] [Full Text] [Related]

  • 10. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.
    Navaneethan U, Venkatesh PG, Lashner BA, Shen B, Kiran RP.
    Aliment Pharmacol Ther; 2012 May 29; 35(9):1045-53. PubMed ID: 22428605
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
    Terg R, Sambuelli A, Coronel E, Mazzuco J, Cartier M, Negreira S, Muñoz A, Gil A, Miguez C, Huernos S, Romero G, Goncalvez S, Levi D, Abecasis R.
    Acta Gastroenterol Latinoam; 2008 Mar 29; 38(1):26-33. PubMed ID: 18533354
    [Abstract] [Full Text] [Related]

  • 12. Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma.
    Aitola P, Mattila J, Matikainen M.
    Int J Colorectal Dis; 2000 Jun 29; 15(3):167-71. PubMed ID: 10954188
    [Abstract] [Full Text] [Related]

  • 13. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.
    Broomé U, Löfberg R, Veress B, Eriksson LS.
    Hepatology; 1995 Nov 29; 22(5):1404-8. PubMed ID: 7590655
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB, Janse M, Blokzijl H, Weersma RK.
    World J Gastroenterol; 2015 Feb 14; 21(6):1956-71. PubMed ID: 25684965
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
    Zheng HH, Jiang XL.
    Eur J Gastroenterol Hepatol; 2016 Apr 14; 28(4):383-90. PubMed ID: 26938805
    [Abstract] [Full Text] [Related]

  • 18. Clinical course of primary sclerosing cholangitis and concomitant ulcerative colitis - a preliminary report of retrospective study among patients from Southern Poland.
    Głowacki MK, Zwolińska-Wcisło M, Frączek P, Gomulska M, Owczarek D, Cibor D, Cieśla A, Mach T.
    Folia Med Cracov; 2015 Apr 14; 55(2):61-8. PubMed ID: 26839244
    [Abstract] [Full Text] [Related]

  • 19. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases.
    Florin TH, Pandeya N, Radford-Smith GL.
    Gut; 2004 Jul 14; 53(7):973-9. PubMed ID: 15194646
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.